On November 24, 2023, the "2023 Fudan Summit on Drug Innovation" hosted by the School of Pharmacy, Fudan University, opened in Zhangjiang, Shanghai. The event attracted approximately 20,000 participants both online and offline.
The two-day summit featured sub-forums on "Discovery of Original Drug Targets," "Discovery of Original Drugs," "Research on Advanced Formulations," and "New Technologies and Clinical Evaluation in Pharmaceuticals," as well as roundtable forums on "New Paths for Interdisciplinary Integration in Biomedicine" and "Opportunities and Challenges in the Transformation of Innovative Pharmaceutical Achievements from Universities."
Professor ZHAO Bing, the Principal Scientist of bioGenous, was invited to attend the summit and delivered a keynote speech titled "Applications of Organoid Technology in Disease Modeling and Translational Medicine." Additionally, he engaged in discussions with other attendees on the sub-forum theme of "New Technologies and Clinical Evaluation in Pharmaceuticals."
